Skip to main content
Supplement Research and Comparison WebsiteBest Price Guarantee
Supplement Research and Comparison Website

Abstract

Preventative effects of Lactobacillus fermentum and Bacillus coagulans against Clostridium perfringens infection in broilers have been well-demonstrated. The present study was conducted to investigate the modulation of these two probiotics on intestinal immunity and microbiota of C. perfringens-challenged birds. The 336 one-day-old broilers were assigned to four groups with six replicates in each group. Birds in the control were unchallenged and fed a basal diet, and birds in the three challenged groups were dietary supplemented with nothing (Cp group), 1 × 109 CFU/kg of L. fermentum (Lf_Cp group), or 1 × 1010 CFU/kg of B. coagulans (Bc_Cp group). Challenge was performed from days 14 to 20, and samples were collected on days 21 and 28. Challenge upregulated interleukin (IL)-1β and transforming growth factor (TGF)-β4 mRNA expression in jejunum on day 21, which was downregulated by B. coagulans and L. fermentum, respectively (P < 0.05). Both probiotic groups upregulated jejunal IL-1β, interferon (IFN)-γ, IL-17, and TGF-β4 on day 28 as well as IFN-γ on day 21 (P < 0.05). The Bc_Cp group increased CD3+ T cell counts in the jejunal crypt on day 21 (P < 0.05). Challenge decreased the ileal ACE index on day 21 and cecal microbial richness on day 28, which were increased by probiotic treatments, and ileal bacterial richness decreased in the Bc_Cp group on day 28 (P < 0.05). Only ileal microbiota on day 21 was distinctly affected with an R-value at 0.3116 by ANOSIM analysis (P < 0.05). Compared with the control, ileal Firmicutes increased on day 21, and ileal Bacteroidetes and cecal Proteobacteria decreased on day 28 in challenged groups (P < 0.05). Challenge increased Romboutsia spp. in the ileum as well as unclassified f_Lachnospiraceae and Ruminococcus_torques group in the cecum, and decreased Lactobacillus spp. in the ileum on day 21, which were all conversely modulated by L. fermentum (P < 0.05). Challenge increased amino acid metabolism of ileal microbiota and membrane transport of cecal microbiota, and decreased amino acid metabolism of cecal microbiota on day 21, which were conversely regulated by both probiotics (P < 0.05). In conclusion, L. fermentum and B. coagulans attenuated the intestinal inflammation and microbial dysbiosis soon after C. perfringens challenge.

Keywords: Bacillus coagulans; Clostridium perfringens; Lactobacillus fermentum; broiler chicken; gut microbiota; immunity.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Bacillus coagulansImproved Immune ResponseBeneficial
Moderate
Bacillus coagulansImproved Microbial RichnessBeneficial
Moderate
Bacillus coagulansModulated Gut Microbiota CompositionBeneficial
Moderate
Bacillus coagulansReduced Intestinal InflammationBeneficial
Moderate
Bacillus coagulansRegulated Microbiota FunctionBeneficial
Moderate
Bacillus coagulans LactoSpore 1 billion CFUEnhanced Intestinal ImmunityBeneficial
Large
Bacillus coagulans LactoSpore 1 billion CFUImproved Gut HealthBeneficial
Moderate
Bacillus coagulans LactoSpore 1 billion CFUImproved Microbial RichnessBeneficial
Moderate
Bacillus coagulans LactoSpore 1 billion CFUReduced Intestinal InflammationBeneficial
Moderate
Bacillus coagulans LactoSpore 1 billion CFURegulated Gut Microbiota Metabolic FunctionsBeneficial
Large
Bacillus coagulans ProDuraImproved Microbial RichnessBeneficial
Moderate
Bacillus coagulans ProDuraIncreased CD3+ T Cell Counts in Jejunal CryptBeneficial
Moderate
Bacillus coagulans ProDuraModulated Amino Acid Metabolism in MicrobiotaBeneficial
Moderate
Bacillus coagulans ProDuraReduced Ileal Firmicutes IncreaseBeneficial
Moderate
Bacillus coagulans ProDuraReduced Interleukin-1β ExpressionBeneficial
Moderate
Bacillus coagulans SC208Reduced Intestinal InflammationBeneficial
Moderate
Bacillus coagulans SNZ-1969Improved Intestinal Immune ResponseBeneficial
Moderate
Bacillus coagulans SNZ-1969Increased Microbial Richness in the Large IntestineBeneficial
Moderate
Bacillus coagulans SNZ-1969Optimized Gut Microbiota CompositionBeneficial
Moderate
Bacillus coagulans SNZ-1969Reduced Intestinal InflammationBeneficial
Moderate
Bacillus coagulans Unique IS-2Enhanced T-Cell ResponseBeneficial
Moderate
Bacillus coagulans Unique IS-2Improved Gut Microbiota RichnessBeneficial
Moderate
Bacillus coagulans Unique IS-2Modulated Gut Microbiota CompositionBeneficial
Moderate
Bacillus coagulans Unique IS-2Reduced Intestinal InflammationBeneficial
Moderate
Lactobacillus fermentumEnhanced Beneficial Microbial PopulationsBeneficial
Moderate
Lactobacillus fermentumEnhanced Intestinal ImmunityBeneficial
Large
Lactobacillus fermentumImproved Amino Acid MetabolismBeneficial
Small
Lactobacillus fermentumReduced Intestinal InflammationBeneficial
Moderate
Lactobacillus fermentum HA-179Improved Gut Microbial DiversityBeneficial
Moderate
Lactobacillus fermentum HA-179Improved Gut Microbiome CompositionBeneficial
Moderate
Lactobacillus fermentum HA-179Improved Microbial Metabolism RegulationBeneficial
Moderate
Lactobacillus fermentum HA-179Modulated Immune ResponseBeneficial
Large
Lactobacillus fermentum HA-179Reduced Intestinal InflammationBeneficial
Moderate
Lactobacillus fermentum Lf-33Improved Gut Microbial RichnessBeneficial
Moderate
Lactobacillus fermentum Lf-33Improved Immune ResponseBeneficial
Moderate
Lactobacillus fermentum Lf-33Optimized Gut Microbiota CompositionBeneficial
Moderate
Lactobacillus fermentum Lf-33Reduced Intestinal InflammationBeneficial
Moderate
Lactobacillus fermentum Lf-33Regulated Metabolic FunctionBeneficial
Moderate
Lactobacillus fermentum LF61Reduced Intestinal InflammationBeneficial
Moderate
Lactobacillus fermentum MAK20L13FImproved Gut Microbial RichnessBeneficial
Moderate
Lactobacillus fermentum MAK20L13FImproved Immune ResponseBeneficial
Moderate
Lactobacillus fermentum MAK20L13FIncreased T Cell CountBeneficial
Moderate
Lactobacillus fermentum MAK20L13FModulated Gut Microbiota CompositionBeneficial
Moderate
Lactobacillus fermentum MAK20L13FReduced Intestinal InflammationBeneficial
Moderate
Lactobacillus fermentum MAK20L13FRegulated Gut Microbiota Metabolic FunctionBeneficial
Moderate
Lactobacillus fermentum ME-3Improved Gut Microbiome CompositionBeneficial
Moderate
Lactobacillus fermentum ME-3Increased Immune Cell PresenceBeneficial
Moderate
Lactobacillus fermentum ME-3Reduced Intestinal InflammationBeneficial
Moderate
Lactobacillus fermentum ME-3Regulated Microbial MetabolismBeneficial
Moderate
Lactobacillus fermentum UALf-32Altered Gut Microbiota CompositionBeneficial
Moderate
Lactobacillus fermentum UALf-32Improved Immune ResponseBeneficial
Moderate
Lactobacillus fermentum UALf-32Improved Microbial RichnessBeneficial
Moderate
Lactobacillus fermentum UALf-32Reduced Intestinal InflammationBeneficial
Moderate
Lactobacillus fermentum UALf-32Stabilized Amino Acid MetabolismBeneficial
Moderate
Lactobacillus fermentum VPro 14Altered Microbial CompositionBeneficial
Moderate
Lactobacillus fermentum VPro 14Enhanced Jejunal Immune ResponseBeneficial
Moderate
Lactobacillus fermentum VPro 14Improved Amino Acid MetabolismBeneficial
Small
Lactobacillus fermentum VPro 14Improved Jejunal T-Cell CountBeneficial
Moderate
Lactobacillus fermentum VPro 14Reduced Intestinal InflammationBeneficial
Moderate
Back to top